Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of salvianolic acid A freeze-dried powder injection and its preparation medicine use

A technology for freeze-dried powder injection and salvianolic acid, which is applied in the field of salvianolic acid A freeze-dried powder for injection and preparation of medicines

Active Publication Date: 2016-01-06
JIANGZI QINGFENG PHARMACEUTICALS INC
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is still a big gap between this and the requirements of actual industrialization

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of salvianolic acid A freeze-dried powder injection and its preparation medicine use
  • A kind of salvianolic acid A freeze-dried powder injection and its preparation medicine use
  • A kind of salvianolic acid A freeze-dried powder injection and its preparation medicine use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0114] Take Danshen medicinal materials, crush them into 6 mesh particles, add 7 times the amount of 92℃ water each time, warm soak and extract 3 times, while stirring at 25 rpm, each warm soak and extract 3 hours; the extract is concentrated under reduced pressure to relative Density 1.20 (60℃), add ethanol to make the alcohol content 70%, let stand, filter, the filtrate is decompressed to recover the ethanol and concentrated to no alcohol; dilute with water to 20mg of salvianolic acid B per 1ml, use 10% of the aqueous solution Adjust pH to 4.0 with sodium hydroxide, add 0.5% ZnCl 2 As a catalyst, heat conversion at 120°C for 4 hours. The conversion solution was adjusted to pH 2.5 with 20% phosphoric acid, centrifuged, and the supernatant was concentrated under reduced pressure to contain 3mg of salvianolic acid A per 1ml, and then subjected to HPD-100 macroporous resin column chromatography Separation, the ratio of loading amount of salvianolic acid A to the macroporous adsorp...

Embodiment 2

[0117] Take Danshen medicinal materials and crush them into granules with a diameter of about 2mm. Add 7 times the amount of water at 90℃ each time and extract 3 times with warm immersion. At the same time, they are stirred at a speed of 25 rpm. Each warm immersion is extracted for 3 hours; the extract is concentrated to The relative density is 1.18 (60℃), add ethanol to make the alcohol content 70%, let stand, filter, the filtrate is decompressed to recover the ethanol and concentrated to no alcohol; dilute with water to 20mg of salvianolic acid B per 1ml, use 10 % Sodium hydroxide adjust the pH to 5.5, add 0.5% ZnCl 2 As a catalyst, heat conversion at 120°C for 4 hours. The conversion solution was adjusted to pH 2.5 with 20% phosphoric acid, centrifuged, and the supernatant was concentrated under reduced pressure to contain 3mg of salvianolic acid A per 1ml, and then subjected to HPD-100 macroporous resin column chromatography Separation, the ratio of loading amount of salvian...

Embodiment 3

[0120] Take Danshen medicinal materials, cut into decoction pieces, add 8 times each time to 85℃ water temperature immersion extraction 3 times, while stirring at 20 rpm, each warm immersion extraction 2.5 hours; the extract is concentrated under reduced pressure to a relative density of 1.17 (60 ℃), add ethanol to make the alcohol content 75%, stand still, filter, the filtrate is decompressed to recover ethanol and concentrated to no alcohol; dilute with water to contain 15mg of salvianolic acid B per 1ml, adjust the aqueous solution with 10% potassium hydroxide pH to 5.0, add 0.6% ZnCl 2 As a catalyst, heat conversion at 120℃ for 3.5 hours. The conversion solution was adjusted to pH 2.5 with 15% hydrochloric acid, centrifuged, and the supernatant was concentrated under reduced pressure to contain 5mg of salvianolic acid A per 1ml, and then passed through HPD-100 macroporous resin column. Analyze and separate, the ratio of loading amount of salvianolic acid A to macroporous ads...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to application of a salvianolic acid A freeze-dried powder to preparation of medicine for preventing and treating ischemic heart disease. The salvianolic acid A freeze-dried powder contains a salvianolic acid A main ingredient, a filler and an antioxidant in the following weight proportion: 10g-80g of the salvianolic acid A main ingredient, 10g-80g of the filler and the antioxidant accounting for 0.01%-0.2% of the total amount. The filler is one or more selected from mannitol, glucose and lactose. The antioxidant is one or more selected from vitamin C, thiourea, sodium bisulfite and sodium pyrosulfite. The salvianolic acid A main ingredient comprises salvianolic acid A more than 93% and less than 100%, and other four components: 0.1%-2% of alkannic acid, 0.1%-2% of rosmarinic acid, 0.1%-2% of salvianolic acid B, and 0.1%-2% of salvianolic acid C.

Description

Technical field [0001] The invention relates to a salvianolic acid A freeze-dried powder injection and its use in preparing medicines. technical background [0002] Ischemic heart disease (IHD) is myocardial damage caused by the imbalance between coronary blood flow and myocardial demand caused by changes in coronary circulation. The most common causes are coronary atherosclerosis, coronary thrombosis, and coronary artery spasm. , Accounting for about 90% of ischemic heart disease. The common point is that due to the insufficiency of myocardial blood supply, the contradiction between oxygen supply and demand results in myocardial ischemia, hypoxia, abnormal myocardial energy metabolism, and inability to support the normal work of the heart, resulting in a series of pathophysiological changes and symptoms, causing angina pectoris and even Myocardial infarction is life-threatening. According to the location, scope and severity of coronary artery disease, and the degree of myocard...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/343A61K31/216A61K9/19A61P9/10A61P9/00A61P7/02A61J3/02C07C69/732C07C67/32
Inventor 崔刚欧阳婷李志勇程帆刘鹏刘恩位王振罗恒真
Owner JIANGZI QINGFENG PHARMACEUTICALS INC